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Summary
 
Surface-expressed immunoglobulin (Ig) has been shown to have a critical role in allelic exclu-
sion of Ig heavy (H) and light (L) chains. Although various degrees of suppression of endoge-
nous Ig expression are observed in Ig transgenic (Tg) mice, it was not clear whether this differ-
ence is due to different onsets of Tg expression or to different levels of Tg expression, which
are obviously affected by integration sites of the transgene. In this study we generated anti-
erythrocyte antibody Tg mice that carry tandem joined H and L chain transgenes (H
 
1
 
L) and
confirmed that homozygosity of the transgene loci enhances the level of transgene expression as
compared with heterozygosity. Suppression of endogenous H and L chain gene expression was
stronger in homozygous than in heterozygous Tg mice. Similar results were obtained in con-
trol Tg mice carrying the H chain only. These results suggest that there is a threshold of the B
cell receptor expression level that induces allelic exclusion. In addition, despite the same B cell
receptor specificity, the size of Tg autoreactive B-1 cell compartment in the peritoneal cavity is
larger in homozygous than in heterozygous mice, although the number of the Tg B-2 cell sub-
set decreased in the spleen and bone marrow of homozygous Tg mice as compared with het-
erozygous Tg mice. By contrast, homozygosity of the H chain alone Tg line, which does not
recognize self-antigens, did not increase the size of the peritoneal B-1 subset. These results sug-
gest that the size of the B-1 cell subset in the Tg mice may depend on strength of signals
through B cell receptors triggered by self-antigens.
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locus of one allele of the B cell results in suppression of
V
 
H
 
D
 
H
 
J
 
H 
 
recombination in the other allele. Thus, a B cell
expresses generally only one H chain gene out of two alleles
(1). This phenomenon is called H chain allelic exclusion.
Surface expression of the 
 
m
 
 chain has a critical role in allelic
exclusion of the H chain locus because targeted disruption
of the 
 
m
 
 chain membrane exon results in loss of H chain al-
lelic exclusion (2). The essential role of the cell surface 
 
m
 
chain expression in allelic exclusion is also supported by
studies using Ig transgenic (Tg)
 
1
 
 mice (3). Mice expressing
the membrane-form 
 
m
 
 chain transgene inhibit expression
of the endogenous 
 
m
 
 chain, whereas Tg mice with the se-
creted form 
 
m
 
 chain do not show such inhibition (4–6). In
addition, expression of Ig L chain transgenes also exerts
suppression on the rearrangement and expression of the en-
dogenous L chain Ig locus (6, 7). However, the suppression
of endogenous H and L chain gene expression in Ig Tg
mice are generally not complete, and efficiencies of the
suppression are variable among different lines of Tg mice
(8–17). Variable integration sites of transgenes may influ-
ence the onset and level of transgene expression, which
may affect the efficiency of allelic exclusion. Since the
V(D)J recombination event in each B cell is all or none, it
has not been clear whether allelic exclusion can be induced
by a small number of surface 
 
m
 
 chain or if it requires a rela-
tively higher number of surface 
 
m
 
 chain (a threshold). To
examine these possibilities, quantitative comparison be-
tween the levels of transgene expression and suppression of
endogenous H and L chain gene expression should be car-
ried out using Tg lines with the same integration site to
avoid the difference due to the developmental onset of
transgene expression.
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell receptor; H
 
1
 
L mice, tandem
joined H and L chain transgenic mice; H
 
3
 
L mice, double transgenic
mice with H and L chain transgenes; Id, idiotype; MFI, mean fluores-
cence intensity; SA, streptavidin; Tg, transgenic. 
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We have generated Tg mice that produce an autoanti-
body (4C8) to RBCs, and have analyzed the mechanisms
of B cell tolerance and B-1 cell activation (18–24). Since
autoreactive B cells are eliminated at the immature stage in
the bone marrow, the number of self-reactive B cells is
markedly decreased in the bone marrow, peripheral blood,
spleen, and lymph nodes in the Tg mice. In contrast, the
peritoneal cavities of the Tg mice contain a normal number
of autoreactive B-1 cells that can be eliminated by interac-
tion with RBCs (18, 19). B-1 cells show distinct surface
antigen expression and anatomical localization from con-
ventional B (B-2) cells (25–28). Furthermore, the V
 
H
 
 gene
usage, N region diversity, and antigen specificity of B-1
cells are also unique (29–34). B-1 cells are thought to be
generated from fetal liver cells, and two independent stud-
ies have demonstrated that adult bone marrow cells do not
give rise to CD5
 
1
 
 B-1
 
 
 
cells after transfer to irradiated hosts
(35, 36). In contrast, Wortis and colleagues (37–39) have
shown that adult bone marrow contains precursors for
CD5
 
1
 
 
 
cells and that CD5 expression in splenic B cells is in-
duced by surface IgM cross-linking, suggesting that B-1
cells are generated from common precursors to conven-
tional B cells. Arnold, Clarke, and colleagues (40, 41) have
reported that B-1 cells differentiate from B-0 cells after ex-
pression of specific antigen receptors. Thus, it is not yet
clear whether B-1 cells constitute a B cell lineage distinct
from conventional B cells. In addition, even if some B-1
cells are derived from activation of B-2 cells, it is not clear
whether a certain threshold level of B cell receptor (BCR)
expression is required for B-1 cell differentiation or if the
receptor specificity alone plays a major role.
To answer these questions we generated new lines of
anti-RBC antibody Tg mice that carried tandem joined H
and L chain (H
 
1
 
L) transgenes, and we compared the levels
of allelic exclusion and the size of B-1 cell compartment
between homozygotes and heterozygotes that differ only in
the level of the surface Ig expression. Suppression of en-
dogenous H and L chain gene expression was more promi-
nent in homozygotes than in heterozygotes, suggesting that
allelic exclusion depends on a certain level of surface Ig ex-
pression. In addition, the size of the Tg B-1 cell compart-
ment in the peritoneal cavity is larger in homozygous than
in heterozygous H
 
1
 
L mice, suggesting that the increase in
the B-1 cell compartment in the Tg mice may be due to
augmentation of signals through surface Ig by the self-anti-
gen (RBC).
 
Materials and Methods
 
Tg Mice.
 
Tg mouse lines carrying either H or L chain gene
for the anti-RBC mAb (4C8 mAb) have been established previ-
ously (18). Double Tg (H
 
3
 
L) mice with H and L chain trans-
genes were obtained by mating H and L chain Tg mice. In this
study we generated new lines of 4C8 mAb Tg mice that carried
tandem joined H and L chain transgenes. To construct tandem
joined transgenes, a 5.6-kb BamHI fragment of pMO-
 
k
 
4C8 was
first subcloned in the BamHI site of pSP73 Vector (Promega
Corp.). Next, a 15.5-kb XhoI fragment of pMO-
 
m
 
4C8 was sub-
 
cloned between the SalI and XhoI sites. The pSP73 plasmid con-
taining both H and L chain genes was designated as pSP73-
 
km
 
4C8. Tandem joined H and L chain Tg (H
 
1
 
L) mice were
generated by injecting a 22.0-kb PvuI–XhoI fragment of pSP73-
 
km
 
4C8 (see Fig. 1 A). Heterozygous mice were mated to get ho-
mozygous mice in two representative lines, H
 
1
 
L5, with 4–12
copies, and H
 
1
 
L6, with 1–3 copies of the transgene. The pres-
ence of the transgenes and homozygosity of the Tg loci were
screened by PCR and Southern blot analysis. Tg mice were
maintained under conventional conditions in our animal facility.
 
PCR Analysis.
 
Mice were typed by PCR analysis of tail
DNA with set of primers to the H and L chain genes. PCR was
carried out for 30 cycles consisting of denaturation (for 1 min at
94
 
8
 
C), annealing (for 1 min at 55
 
8
 
C), and extension (for 2 min at
72
 
8
 
C). The primer pairs for PCR were as follows: 5
 
9
 
Hc, 5
 
9
 
-CTA-
CGCATTTAGTAGTGACTGG-3
 
9
 
; J
 
H
 
3, 5
 
9
 
-TGCAGAGACAG-
TGACCAGAG-3
 
9
 
; IgL5
 
9
 
-2, 5
 
9
 
-CTGCAAGTCCAGTCAGA-
GCC-3
 
9
 
; IgL3
 
9
 
-2, 5
 
9
 
-CAGCACCGAACGTGAGAAAG-3
 
9
 
.
 
Immunological Reagents.
 
FITC- or Cy-Chrome
 
®
 
–conjugated
anti–mouse CD45R (B220), FITC- or PE-conjugated anti–
mouse IgM
 
a 
 
(Igh-6
 
a
 
), FITC- or PE-conjugated anti–mouse IgM
 
b
 
(Igh-6
 
b
 
), PE-conjugated anti–mouse CD11b (Mac-1 
 
a
 
 chain),
biotin-conjugated anti–mouse 
 
l
 
1
 
 and 
 
l
 
2
 
 L chain mAbs, and
FITC- or Cy-Chrome
 
®
 
–conjugated streptavidin (SA) were pur-
chased from PharMingen. FITC- or biotin-conjugated F(ab
 
9
 
)
 
2
 
fragments of goat anti–mouse IgM were from ICN Pharmaceuti-
cals (Cappel). PE-conjugated SA was from Dako. Anti-idiotype
(Id) mAb (S54) against the transgene-encoded anti-RBC anti-
body (4C8) (18) was conjugated with 
 
N
 
-hydroxysuccinimidobi-
otin (Pierce Chemical Co.) according to the directions provided
by the manufacturer.
 
Flow Cytometric Analysis.
 
Single cell suspension from bone
marrow was prepared by flashing femur bones with a staining
buffer (PBS containing 2% FCS and 0.05% sodium azide), gently
pipetted, and washed with the staining buffer. Single cell suspensions
from bone marrow, spleen, and peritoneal cavity were prepared
with the staining buffer and pretreated with 10% heat-inactivated
normal rat serum. After 15 min of incubation, FITC- and/or biotin-
conjugated mAbs at appropriate dilutions in the staining buffer
were added directly. After 30 min of incubation, PE-conjugated
mAbs and/or FITC- or PE-conjugated SA was added. Before
and after each step of incubation, cells were washed with the
staining buffer. Stained cells were then applied to FACSCalibur
 
®
 
(Becton Dickinson). After excluding dead cells by propidium io-
dide staining, cells present in the lymphocyte gate defined by for-
ward and side light scatters were analyzed.
 
Results
 
Surface Expression of the Transgene Is Higher in Homozygous
than in Heterozygous Mice.
 
To assess whether the levels of
transgene expression are higher in homozygous than in
heterozygous mice, we analyzed the bone marrow cells of
H
 
1
 
L5 and H
 
1
 
L6 mice that carried tandem joined H and
L chain transgenes cording for the 4C8 anti-RBC antibody
(Fig. 1 A). In H
 
3
 
L mice, B220
 
1
 
IgM
 
1
 
 bone marrow cells
almost completely disappeared (18). In contrast, both lines
of H
 
1
 
L mice had significant numbers of B220
 
1
 
IgM
 
1
 
 cells
in bone marrow (Fig. 1 B). The majority of these cells
were stained both with antiallotypic mAb for IgM
 
a
 
 (Tg)
and with antiidiotypic mAb (S54) for the anti-RBC anti- 
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body. We compared the fluorescence intensity of Id
 
1
 
 bone
marrow cells in homozygous mice to that in heterozygous
mice (Fig. 1 C). The mean fluorescence intensities (MFI)
of Id
 
1
 
 cells in heterozygous and homozygous H
 
1
 
L5 mice
are 481.70 and 717.42, respectively. Similarly, the MFI of
Id
 
1
 
 cells in heterozygous and homozygous H
 
1
 
L6 mice are
997.76 and 1670.11, respectively. These results indicate
that in both H
 
1
 
L5 and H
 
1
 
L6 lines the levels of transgene
expression are clearly higher in homozygous than in het-
erozygous mice. We also examined surface Ig expression
on the bone marrow cells of H3 Tg mice that had only H
chain transgene. Fluorescence intensity of antiallotypic
mAb for IgM
 
a
 
 (Tg) of bone marrow cells was also stronger
in homozygous (MFI 
 
5 
 
908.77) than in heterozygous
(MFI 
 
5 
 
319.25) mice. In a parallel experiment, anti-IgM
 
a
 
mAb MFI of homozygous H
 
1
 
L5 and H
 
1
 
L6 were 173.07
and 250.72, respectively, indicating that homozygous H
 
1
 
L
B cells had not saturated the capacity of surface Ig expres-
sion (Fig. 1 D). Taken together, homozygosity of Tg Ig
 
loci enhances the level of transgene expression on B cell
surface.
 
Inhibition of Endogenous H Chain Expression Is Stronger in
Homozygous than in Heterozygous Mice.
 
To test whether in-
hibition of endogenous H chain expression is stronger in
homozygous than in heterozygous mice, we analyzed lym-
phocytes in bone marrow and spleen of H
 
1
 
L5, H
 
1
 
L6,
and H3 mice by flow cytometry. We stained bone marrow
and spleen cells with antiallotypic mAbs (which can clearly
distinguish IgM of the control mice; Fig. 2, A and B) for
IgM
 
a
 
 (Tg) and IgM
 
b
 
 (endogenous). In all heterozygous Tg
mice, the numbers of IgM
 
a
 
1
 
IgM
 
b
 
1
 
 
 
cells (allelic inclusion)
were small but significant, whereas these cells almost com-
pletely disappeared in all homozygous Tg mice. This con-
clusion is further confirmed by the finding that both bone
marrow and spleen B cells with only endogenous H chains
(IgM
 
a
 
2
 
IgM
 
b
 
1
 
) decreased in homozygous Tg mice as com-
pared with heterozygous Tg mice (Fig. 2, A and B). In all
lines of Tg mice, total numbers of endogenous H chain–
Figure 1. Structure and expression of anti-RBC transgene. (A) Tg construct with tandem joined H and L chain genes. DNA fragments of the L and H
chain genes are shown by arrows. Exons are represented by open boxes. Relevant restriction sites are shown: B, BamHI; E, EcoRI; X, XhoI; K, KpnI;
P, PvuI. (B) Flow cytometric analysis of bone marrow cells in Tg mice. Bone marrow cells were isolated from heterozygous (hetero) H1L5, homozy-
gous (homo) H1L5, hetero H1L6, homo H1L6, C57BL/6, and H3L mice at 10–14 wk of age and stained with biotin-conjugated goat anti–mouse
IgM antibody, followed with FITC-conjugated anti-B220 antibody and Cy-Chrome®–conjugated SA. The percentages of B2201IgM1 cells of the gated
region in the total viable cells are indicated in each panel. (C) Flow cytometric analysis for surface expression of the Tg Ig in heterozygotes and homozy-
gotes. Bone marrow cells were isolated from heterozygous (thin line) or homozygous Tg mice (thick line) of H1L5, H1L6, and H3 mice at 10–14 wk
of age. Bone marrow cells were stained with either biotin-conjugated anti-Id antibody (S54) followed by PE-conjugated SA or FITC-conjugated antial-
lotypic antibody for IgMa (Tg). (D) Flow cytometric analysis of relative surface Tg expression in homozygous Tg lines. Staining was done as described in
panel C using FITC-conjugated anti-IgMa antibody.464 Quantitative Effects of Surface Ig Levels on Allelic Exclusion
expressing (IgMb1) spleen cells were lower in homozygous
than in heterozygous mice (Fig. 2 C). These results indicate
that inhibition of endogenous H chain expression (allelic
exclusion) is stronger in homozygous than in heterozygous
mice. Taken together, higher levels of Ig transgene expres-
sion appear to cause stronger inhibition of endogenous H
chain expression, suggesting that a certain level of surface
Ig expression is required for allelic exclusion of the H chain
locus.
Inhibition of Endogenous L Chain Expression Is Stronger in
Homozygous Mice than in Heterozygous Mice. Next, we asked
whether homozygosity of Tg loci also reduces endogenous
L chain expression. Since the allotypic specificity for the Tg
Lk chain is not known, we estimated the degree of endog-
enous L chain expression by difference in expression of Tg
H chain (IgMa) and Id (the combined epitope of the H and
L chains of the 4C8 anti-RBC mAb) that is recognized by
the S54 mAb. In the H1L5 line, two populations of IgMa1
cells were observed: one stained with both anti-IgMa and
anti-Id mAbs diagonally, and the other stained more
weakly with anti-Id mAb than with anti-IgMa mAb (Fig. 3,
A, B, and D, tops). As a control, IgMa1 cells from H3 mice
did not contain the population stained with the S54 mAb
(Fig. 3, B and D, bottoms). We presume that the cells that
stained diagonally with both mAbs express the Tg H and L
chains equally, and that the IgMa1Idlow cells express the Tg
H chain with both endogenous and Tg L chains. In support
of this assumption, IgMa1 bone marrow cells in heterozy-
gous H1L6 mice, which consisted of almost exclusively
IgMa1Id1 cells and only few IgMa1Idlow cells, contained
,1.2% l1 cells, which represent a fraction of B cells that
express endogenous L chains (Fig. 3 A). In contrast, IgMa1
bone marrow cells in heterozygous H1L5 mice, which
consisted of z28% IgMa1Id1 and z72% IgMa1Idlow cells,
contained .5.5% l1 cells (Fig. 3 A). Furthermore, IgMa1
spleen cells in heterozygous H1L5 mice, which consisted
of z4% IgMa1Id1 and z96% IgMa1Idlow cells, contained
.14% l1 cells (Fig. 3 A). The total number of cells ex-
pressing endogenous L chains (IgMa1Idlow) in bone marrow
(Fig. 3, B and C) and spleen (Fig. 3, D and E) was less in
homozygous than in heterozygous Tg lines, indicating that
homozygosity of the Tg loci enhances the inhibition of en-
dogenous L chain expression as compared with heterozy-
gosity.
The Size of an Autoreactive B1 Cell Compartment Is Larger
in Homozygous Mice than in Heterozygous H1L Mice.
H3L mice show almost complete deletion of autoreactive
B cells from bone marrow and spleen, whereas a normal
level of B-1 cells is found in the peritoneal cavity (18).
Bone marrow of both lines of H1L mice contained some
autoreactive B cells (IgMa1Id1), which have B-2 cell phe-
notypes (CD52B220highIgMlow), whereas autoreactive B
cells in spleen almost completely disappeared in H1L mice
(Fig. 3, B and D). We examined whether homozygosity of
the Ig transgene loci influences the size of the autoreactive
B-1 cell compartment in the peritoneal cavities of H1L5
and H1L6 mice. Peritoneal cells of H1L mice had a lim-
ited number of B2201Id1 cells, almost all of which were
IgMa1 (Fig. 4, A–C and E–G). Almost all Id1 cells in the
peritoneal cavity were Mac11 and therefore belong to the
B-1 subset (Fig. 4, D and H). Thus, IgMa1Id1 cells are
most likely to be autoreactive B-1 cells (Fig. 4, C and G).
These B2201Id1 cells in the peritoneal cavity were much
more abundant in homozygous H1L mice than in het-
erozygous H1L mice, indicating that the size of the au-
toreactive B-1 cell subset is larger in homozygous than in
heterozygous H1L mice. The relative size of the B-1 cell
compartment is directly proportional to the B-1 cell num-
ber because total cell numbers in the peritoneal cavity did
not vary between homozygous and heterozygous Tg mice.
These results suggest that a higher expression level of the
autoantibody facilitates the increase in autoreactive B-1
cells in the peritoneal cavity.
To test whether autoreactivity of Ig expressed on B cells
Figure 2. Tg H chain expression in B
cells of heterozygous or homozygous H1L
and H3 Tg mice. Cells were isolated from
bone marrow (A) and spleen (B) of indi-
cated mice at 10–14 wk of age and stained
with FITC-conjugated antiallotypic anti-
body for IgMa (Tg) and PE-conjugated an-
tiallotypic antibody for IgMb (endogenous).
Control stainings of IgMa (BALB/c) and
IgMb (C57BL/6) spleen cells are shown. The percentages of cells of each gated region in total viable cells are indicated. Total numbers of the cells with
endogenous H chains in heterozygous or homozygous H1L5, H1L6, and H3 Tg mice are shown (C). Spleen cells were stained and analyzed from at
least three mice of each Tg line. Numbers of indicated cells were calculated by (percentage of indicated cells in viable cells) 3 (No. of viable cells). Re-
sults are expressed as mean 6 SD.465 Watanabe et al.
is crucial to enlargement of the B-1 cell subset, we carried
out similar studies on the peritoneal B cells in H3 Tg mice,
the vast majority of which are not autoreactive due to the
absence of the Tg L chain. The majority of peritoneal B
cells expressed the Tg H chain (IgMa1), in agreement with
analysis of bone marrow and spleen cells (Fig. 4, I and J).
Indeed, B cells expressing endogenous H chains were less
in homozygous than in heterozygous H3 mice (Fig. 4 J),
probably because of more efficient allelic exclusion due to
stronger expression of the transgene product on homozy-
gous B cells (Fig. 1 C). Nonetheless, the percentage of
IgM1Mac11 cells in the peritoneal cavity did not increase
in homozygous H3 mice as compared with those in het-
erozygous H3 mice (Fig. 4 K). These results indicate that
increased surface Ig expression of non-auto-reactive B cells
did not facilitate enlargement of the B-1 cell subset in the
peritoneal cavity. Taken together, enhancement of autore-
active surface Ig expression appears to be crucial to increase
the B-1 cell subset in the peritoneal cavity.
Discussion
In this study, we generated new lines of the anti-RBC
antibody Tg mice that carry tandem joined H and L chain
transgenes, and compared B cell phenotypes between het-
erozygous and homozygous Tg mice to evaluate quantita-
tively the effect of surface Ig level on allelic exclusion and
B-1 cell development. Higher levels of surface Tg Ig ex-
pression resulted in (a) stronger clonal deletion of B-2 cells
from bone marrow and spleen; (b) reduction of B cells ex-
pressing endogenous H or L chains; and (c) enlargement of
the autoreactive B-1 cell subset in the peritoneal cavity.
Several lines of evidence suggest that surface expression
of the m chain is critical for H chain allelic exclusion (2, 4–6).
In addition, pre-BCR, which is the H chain paired with
the surrogate L chain, is suggested to mediate H chain al-
lelic exclusion through downregulation of recombination-
activating genes (42–46). Iga and Igb, which associate with
surface-expressed H chains, have also been shown to trig-
ger the signals inducing allelic exclusion (47–49). Taken
together, expression of the H chain as a pre-BCR on the
cell surface may induce signals mediated by Iga and Igb,
resulting in H chain allelic exclusion. In this study we have
demonstrated that homozygosity of the transgene Ig loci
increases surface Ig expression on bone marrow B cells and
causes stronger allelic exclusion, as compared with het-
erozygosity. Since allelic exclusion is all or none in each B
cell, the present results suggest that there is a threshold of
the pre-BCR signal intensity that induces allelic exclusion.
There are several other possibilities to explain our results.
First, B cells with allelic inclusion may be negatively se-
lected. However, Sonoda and Rajewsky (50) have shown
that B cells with allelic inclusion can normally expand in
the periphery using double Ig knock-in mice, indicating
Figure 3. Tg Id expression in B cells of heterozygous or homozygous
H1L5, H1L6 and H3 Tg mice. Cells were isolated from bone marrow
(A and B) and spleen (A and D) of mice at 10–14 wk of age and stained
with FITC-conjugated antiallotypic antibody for IgMa (Tg) and biotin-
conjugated anti-Id (A, B, and D) or biotin-conjugated anti-l antibody
(A) coupled with PE-conjugated SA. The percentages of the cells of each
gated region in total viable cells are indicated. Note that results from dif-
ferent mice are shown for A than for B–E. Total numbers of the bone
marrow (C) and spleen (E) cells expressing endogenous L chain and Tg H
chain in heterozygous or homozygous H1L5 and H1L6 Tg mice. Cells
were analyzed from at least three mice in each line. Numbers of indicated
cells were calculated by (percentage of indicated cells in viable cells) 3
(No. of viable cells). Results are expressed as mean 6 SD.466 Quantitative Effects of Surface Ig Levels on Allelic Exclusion
the absence of negative selection against allelic inclusion B
cells. In addition, we have shown that endogenous only B
cells (IgMa2IgMb1) are also reduced in homozygotes (Fig.
2). Second, reduction of allelic inclusion B cells could be
due to selective expansion of higher surface Ig-expressing
cells by a self-antigen. However, the self-antigen (RBC)
can kill self-reactive B cells (19). In fact, Id1 B cells of
H1L mice decreased in homozygotes as compared with
heterozygotes in spleen as well as in bone marrow (Fig. 3,
B and D). In addition, we have shown that non–self-reac-
tive (H chain alone expressing) Tg (H3) B cells also show
suppression of endogenous Ig expression (Fig. 2). These re-
sults cannot be explained by positive selection of self-reac-
tive Ig expressing B cells by the self-antigen. Third, excess
Tg Ig expression on surface may inhibit detection of en-
dogenous Ig expression. It is unlikely that endogenous and
Tg Ig molecules compete for surface expression in H1L5
and H1L6 spleen cells. This is because the surface Ig levels
of homozygous H3, H1L6, and H1L5 cells are 909, 251,
and 173 (MFI using the anti-IgMa Ab), respectively (Fig. 1
D), indicating that H1L5 and H1L6 B cells have not hit
the ceiling of the surface Ig expression level. Sonoda and
Rajewsky (50) have shown that there is no inhibitory
mechanism for the H chain on the surface as long as it can
associate with the L chain. It is inconceivable that the sur-
face expression efficiency differs between H chains derived
from the transgene and endogenous gene. The possibility
that a lower detection efficiency by anti-IgMb Ab staining
in the presence of large amounts of IgMa is also unlikely
because the FACS® profiles of H3 spleen cells expressing
large amounts of IgMa clearly show the presence of IgMa
IgMb double-positive cells even in homozygotes (Fig. 2 B).
Finally, the suppression efficiency of the endogenous locus
may be increased in homozygotes simply because the fre-
quency of silencing the transgene locus is reduced by dou-
bling the number of the transgene locus in homozygotes.
Assuming that this is the case, the efficiency of silencing of
the transgene locus can be calculated from the endogenous
H chain only cells shown in Fig. 2 A: H3, 0.06 / (0.06 1
0.11 1 6.50) 5 0.009 in heterozygotes and 0.00144 5
0.01 / (0.01 1 0.03 1 6.9) in homozygotes. The value in
homozygotes is z18 times of the expected value (0.009 3
0.009 5 0.000081) based on the simple statistics. Similar
discrepancy was seen in the H1L5, H1L6, and H3 spleen
cells (Fig. 2 B). In addition, homozygosity alters the num-
ber of Tg Id1 B cells in spleen and peritoneal cavity to the
opposite direction. These considerations make the final
possibility unlikely.
We have shown that H1L Tg mice have B cells express-
ing endogenous L chains together with the Tg H chain.
These cells, expressing endogenous L chains in H1L mice,
may be generated either by incomplete allelic exclusion or
Figure 4. Flow cytometric analysis of peritoneal cells of heterozygous or homozygous H1L5, H1L6, H3L, and H3 Tg mice. Cells were isolated
from peritoneal cavity of mice at 10–14 wk of age and stained with FITC-anti mouse IgM and Cy-Chrome®–conjugated anti–mouse B220 (A, E and I);
biotin-conjugated anti-Id antibody followed by FITC-conjugated SA and Cy-Chrome®–conjugated anti-B220 antibody (B and F); biotin-conjugated
anti-Id antibody followed by FITC-conjugated SA and PE-conjugated antiallotypic antibody for IgMa (C and G); biotin-conjugated anti-Id antibody fol-
lowed by FITC-conjugated SA and PE-conjugated anti–mouse Mac-1 (D and H); FITC-conjugated antiallotypic antibody for IgMb (endogenous) and
PE-conjugated antiallotypic antibody for IgMa (Tg) (J); and FITC-conjugated goat anti–mouse IgM antibody and PE-conjugated anti–mouse Mac-1 (K).
The percentages of the cells of each gated region in total viable cells are indicated. Total peritoneal cell numbers were constant between heterozygous and
homozygous Tg mice.467 Watanabe et al.
by receptor editing because the B cells which express the
transgenes are self-reactive (51, 52). Nemazee and col-
leagues (53–55) have suggested that interaction with au-
toantigens leads IgMlowIgD2 bone marrow cells to undergo
receptor editing but IgMhighIgD1 cells to undergo rapid ap-
optosis. On the other hand, Rusconi et al. (16) generated B
cell hybridomas from anti-trinitrophenol antibody (anti-
non-self) Tg mice that carried tandem joined H and L
chain transgenes and demonstrated that the B cell hybrido-
mas secreting the Tg antibody expressed the Tg L chain at
about one-tenth of the level of coexpressed endogenous L
chains. Endogenous L chain expression in their Tg mice is
probably due to incomplete allelic exclusion because these
B cells are unlikely to receive BCR stimulation by self-anti-
gens to trigger receptor editing. Although we cannot ex-
clude the possibility that receptor editing is involved in the
appearance of B cells with endogenous L chains in our Tg
mice, we think it less likely because of the following rea-
son. If the expression of endogenous L chain is due to re-
ceptor editing induced by stimulation with the self-antigen,
the mechanism to reduce the number of B cells with en-
dogenous L chains by enhanced expression of self-reactive
Ig should be clonal deletion. However, when B cells ex-
pressed more self-reactive Ig on surface, B cells with both
Tg and endogenous L chains (IgMa1Idlow) are more effi-
ciently reduced than Tg only B cells (IgMaId1), which are
most likely eliminated by clonal deletion (Fig. 3). This ob-
servation is somewhat opposed to the expected efficiency
of clonal deletion by the self-antigen because stronger
BCR signaling will be induced in IgMaId1 cells than Ig-
MaIdlow cells.
Although it is still controversial whether B-1 cells belong
to an ontogenetically different B cell lineage from conven-
tional B cells (34–40), B-1 and B-2 cells clearly constitute
different subsets of B cells. In this study we have shown
that the size of the Tg B-1 cell compartment is larger in
homozygous than in heterozygous H1L mice (Fig. 4).
Since Tg B-1 cells in heterozygous and homozygous mice
show the same antigen specificity, our results suggest that
the level of surface Ig expression directly influences the size
of the Tg B-1 cell compartment. Our findings are consis-
tent with the previous observations that defects of BCR
signaling cause reduction of the B1 cell (56, 57), and loss of
a BCR inhibitory molecule, SHP-1, increases the B1 cell
number (58–62). It is important to note that increased lev-
els of autoreactive BCR induced augmented clonal dele-
tion of B-2 cells in bone marrow and spleen but expansion
of B-1 cells in the peritoneal cavity (Fig. 4). Increased ex-
pression of nonautoreactive Ig (H3) enhanced neither
clonal deletion of B-2 cells nor expansion of B-1 cells.
These results suggest that there are at least three levels of
BCR signaling that regulate self-reactive B1 and B2 cell
differentiation. At a lower level, self-reactive B-2 cells can
be stimulated to induce receptor editing or to become an-
ergic (53–55, 63). At an intermediate signaling level, B-2
cells are clonally deleted and B-0 (40, 41) and/or B-2 cells
are induced to differentiate into B-1 cells, which migrate
into the peritoneal cavity. At a strong signaling level, B-1
cells are also clonally deleted (19). It is tempting to specu-
late that at least a sizable fraction of peritoneal B-1 cells
originate and expand from autoreactive B cells that are
stimulated by self-antigens to a level strong enough to be
activated but weak enough to avoid apoptosis.
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